Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 1997

View Archived Issues

Ajinomoto prepares peptides for treating or preventing human gastric cancer

ET antagonists disclosed by Roussel Uclaf

Inhibitors of MHC class II binding from Merck & Co.

Novel progestins/antiprogestins disclosed by Ortho

Synthelabo reveals 5-HT4/5-HT3 receptor ligands

AIREX study shows significant, sustained survival benefit for ramipril in AMI/heart failure patients

FDA advisory committee recommends Corlopam approval

Disappointing phase III results for Ventus

North American Vaccine seeks FDA approval for DTaP-IPV vaccine trial

Atypical antipsychotic from Taisho/Nihon Nohyaku characterized in rats

Effects on cartilage breakdown of orally active collagenase inhibitor, Ro-32-3555

Arris reports positive results from phase IIa trial of tryptase inhibitor for asthma

GelTex bile acid sequestrant not absorbed from GI tract in animals

TCR peptide vaccine induces immune response in MS

PST-2238: a highly potent antihypertensive agent with a novel mechanism of action

ImmuLogic postpones Allervax Ragweed trial

Anika and Orquest sign manufacturing agreement

Preclinical results reported for type I diabetes vaccine

Ube/Tanabe evaluating orally active antiallergic/antiasthmatic agent

Inflazyme's Bispan more potent antiinflammatory agent than currently used antiarthritics

Phytopharm to develop naturally occurring antiobesity agent

The Liposome Company registers shares held by its major investor

Lisofylline not associated with reduction in high-dose IL-2 toxicity